Pregabalin Capsule
Product Images NDC 71610-820

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71610-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0820 30)

FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemical Structure (Pregabalin 01)

FDA Label Image

Figure 1 (Pregabalin 02)

FDA Label Image

Figure 2 (Pregabalin 03)

FDA Label Image

Figure 3 (Pregabalin 04)

This information provides data on the percentage of patients who experienced improvement in pain levels after different treatment regimens involving Pregabalin dosages and a placebo. The percentages range from 0% to 100% across the various dosages of Pregabalin and the placebo.*

FDA Label Image

Figure 4 (Pregabalin 05)

FDA Label Image

Figure 5 (Pregabalin 06)

This data shows the percentage of patients who experienced improvement in pain compared to the baseline after taking different dosages of Pregabalin and placebo. The percentage of improvement is recorded at various intervals for Pregabalin 100 mg three times a day, Pregabalin 50 mg three times a day, and Placebo. The graph visually represents the efficacy of these treatments in reducing pain levels in patients.*

FDA Label Image

Figure 6 (Pregabalin 07)

FDA Label Image

Figure 7 (Pregabalin 08)

FDA Label Image

Figure 9 (Pregabalin 09)

This text provides information on the percentage of patients experiencing improvement in pain after taking different doses of Pregabalin and Placebo. The doses mentioned are 600 mg, 450 mg, and 300 mg per day for Pregabalin, with a comparison to Placebo. It also lists the percentage of improvement in pain from the baseline for each group.*

FDA Label Image

Figure 10 (Pregabalin 10)

FDA Label Image

Figure 11 (Pregabalin 11)

FDA Label Image

Figure 12 (Pregabalin 12)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.